ProCE Banner Series

Viral Hepatitis Update: CCO Independent Conference Coverage of EASL 2023*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

 

Join Stefan Zeuzem, MD, in a live, interactive webinar as he provides rapid updates on treatments for HBV and HDV, HCV treatment and implementation, and guideline updates from the EASL scientific meeting. The faculty will also answer your most pressing questions on how to incorporate these data into practice. 

  AMA
Who Should Attend

This program is intended for physicians and other HCPs who care for patients with or at risk of viral hepatitis.

All Events

Upcoming Events

September

16

2024

CCO Growth Campaigns - For List Uploads Only

11:33 AM - 12:33 PM Eastern European Time (EET)

In-personVirtual

Past Events

June

27

2023

Viral Hepatitis Update: CCO Independent Conference Coverage of EASL 2023*

12:30 PM - 1:15 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
John R. P., Tesser, MD

Adjunct Clinical Associate Professor
Midwestern University College of Osteopathic Medicine
Glendale, Arizona
Senior Partner
Arizona Arthritis & Rheumatology Associates
Phoenix, Arizona

ProCE Banner Faculty
test1 test

ProCE Banner Faculty
Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

PT Faculty

ProCE Banner Faculty
Tanis Dingle, PhD, FCCM, D(ABMM)

Clinical Associate Professor
Department of Pathology and Laboratory Medicine
University of Calgary
Clinical Microbiologist
Public Health Laboratory
Alberta Precision Laboratories
Calgary, Alberta, Canada

Topics

  • Program Overview (5 min)
  • Key Studies (25 min)
    • Hepatitis B
    • Hepatitis Delta
    • Hepatitis C

Question and Answer Session (15 min)

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve learners' competence in translating the most clinically important data from EASL 2023 into practical management strategies for patients with or at risk of viral hepatitis.

Target Audience
This program is intended for physicians and other HCPs who care for patients with or at risk of viral hepatitis.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Incorporate the results of recent clinical studies of HBV and HDV management strategies into clinical practice
  • Evaluate the impact of results of clinical studies of investigational treatments for chronic HBV and HDV infection on current and future patient management strategies
  • Implement new data on strategies for optimizing HCV care, including simplified approaches to HCV management

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grant from Gilead Sciences, Inc.